Key result
PKR variants PKR-M1 and PKR-M7 functioned as transdominant inhibitors of wild-type PKR, with PKR-M7 inhibiting at stoichiometric levels and causing greater reductions in eIF-2 alpha phosphorylation.
PKR variants M1 and M7 exhibit distinct biochemical properties and mechanisms of transdominant inhibition, providing insights into their roles in malignant transformation.
Answers are grounded in this paper and cite their sources.
PKR-M1/M7 may inhibit eIF-2α in models; leaves open their role in malignant transformation.
Double-stranded RNA-dependent protein kinase (PKR) is suggested to play an important role in both the antiviral and antiproliferative arms of the interferon response. To gain insights into the molecular mechanisms underlying PKR's growth regulatory properties, we examined the biological and biochemical properties of PKR variants containing either a mutation in catalytic domain II (PKR-M1) or a deletion of RNA binding domain I (PKR-M7) in both reticulocyte translation extracts and in vitro kinase assays with purified reagents and compared these results with those using the same mutants stably expressed in vivo. While wild-type PKR (PKR-WT) efficiently inhibited mRNA translation in a reticulocyte extract, the inactive PKR-M1 had no effect. The PKR-M7 mutant was modestly inhibitory in this assay. The PKR-M1 variant was able to reverse the translational inhibitory effects and increased eukaryotic initiation factor (eIF)-2 alpha phosphorylation levels caused by addition of double-stranded RNA to reticulocyte extract, whereas PKR-M7 could not. Both PKR-M1 and PKR-M7 functioned as transdominant inhibitors of PKR-WT in our in vitro kinase assays. While the inhibition by PKR-M1 required a vast excess of mutant to shut down PKR function, PKR-M7 inhibited PKR-WT at approximately stoichiometric levels. To complement these experiments, we compared growth rates and alpha phosphorylation levels in transformed cell lines overexpressing either PKR-M1 or PKR-M7. Levels of endogenous eIF-2 alpha phosphorylation were significantly more diminished in PKR-M7 overexpressing cells compared with PKR-M1. These paradoxical data will be discussed in terms of the potential molecular mechanisms underlying malignant transformation caused by the PKR variants.
No takes yet. Share an insight, caveat, or question.
Barber et al. (1995) studied Malignant transformation. PKR variants (PKR-M1 and PKR-M7) vs. Wild-type PKR (PKR-WT) was evaluated on mRNA translation inhibition, eIF-2 alpha phosphorylation levels, and growth rates. PKR variants PKR-M1 and PKR-M7 functioned as transdominant inhibitors of wild-type PKR, with PKR-M7 inhibiting at stoichiometric levels and causing greater reductions in eIF-2 alpha phosphorylation.
Synapse has enriched 10 related papers. Consider them for comparative context: